Skip to content

Trial Summary

Prostate Cancer Registry collecting treatment data on patients with Castrate-Resistant prostate cancer to investigate the outcomes of these treatments.

Acronym:

ePAD

ACTRN/NCT /ethics:

ACTRN12616000585426

Scientific title:

Analyzing Treatment Patterns and Outcomes from Real-World Patients with Castrate-Resistant Prostate Cancer (CRPC)

Sponsor / Cooperative group:

Melb Health

Trial & Patient Characteristics

Cancer TypeProstate
Trial TypeEarly detection, diagnosis, prognosis
Phase-
Age Range18 years and older
SexMale
Tumour Stream -
Cancer StageLocally Recurrent or Locally Advanced
Anticipated Start Date-
Anticipated End Date2021-06-30

Participating Hospitals

HospitalAshford Cancer Centre Research
Clinical Trial CoordinatorSue Yeend
Emailsyeend@adelaidecancercentre.com.au
Phone08 8292 2240
Principal InvestigatorDr Francis Parnis
Recruitment StatusRecruiting